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Biophysics, Chinese Academy of Sciences, Beijing, ChinaABSTRACT Prion diseases are infectious fatal neurodegenerative diseases including Creutzfeldt-Jakob disease in humans
and bovine spongiform encephalopathy in cattle. The misfolding and conversion of cellular PrP in such mammals into patho-
genic PrP is believed to be the key procedure. Rabbits are among the few mammalian species that exhibit resistance to prion
diseases, but little is known about the molecular mechanism underlying such resistance. Here, we report that the crowding
agents Ficoll 70 and dextran 70 have different effects on fibrillization of the recombinant full-length PrPs from different species:
although these agents dramatically promote fibril formation of the proteins from human and cow, they significantly inhibit
fibrillization of the rabbit protein by stabilizing its native state. We also find that fibrils formed by the rabbit protein contain
less b-sheet structure and more a-helix structure than those formed by the proteins from human and cow. In addition, amyloid
fibrils formed by the rabbit protein do not generate a proteinase K-resistant fragment of 15–16-kDa, but those formed by the
proteins from human and cow generate such proteinase K-resistant fragments. Together, these results suggest that the strong
inhibition of fibrillization of the rabbit PrP by the crowded physiological environment and the absence of such a protease-resistant
fragment for the rabbit protein could be two of the reasons why rabbits are resistant to prion diseases.INTRODUCTIONPrions are the heretical protein-only infectious agents
responsible for prion diseases including CJD and kuru in
humans, bovine spongiform encephalopathy in cattle, scra-
pie in sheep, and chronic wasting disease in elk and mule
deer (1–6). The misfolding and conversion of the normal
protease-sensitive cellular prion protein (PrPC) in such
mammals into the aberrant protease-resistant pathogenic
prion protein (PrPSc) is believed to be the key procedure
(1–6), which may require other cofactors (6). Rabbits are
among the few animal species that exhibit resistance to
prion diseases (7), and they survive challenge with the
human kuru and CJD agents as well as with scrapie agent
isolated from sheep or mice (7,8). It has been suggested
that the resistance of rabbits to prion diseases is due to
multiple rabbit PrP-specific amino acid residues (9,10)
that may result in a PrP structure that is unable to misfold
to the abnormal isoform PrPSc (10). The loop connecting
the second b-strand with the second a-helix is well-defined
in rabbit, elk, and mule deer PrPC, whereas it exhibits
pronounced structural disorder in PrPC of mice, humans,
cattle, and sheep (11–13). The x-ray crystallographic struc-
ture of rabbit PrPC has identified a key helix-capping motif
implicated in the resistance of rabbits to prion diseases (14).
Recently, it has been suggested that the rabbit-specific resi-Submitted March 21, 2011, and accepted for publication August 11, 2011.
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0006-3495/11/09/1483/10 $2.00dues surrounding the C-terminal GPI anchor may interfere
with a PrPSc interaction site (15). Furthermore, rabbit PrP
does not induce spongiform degeneration and does not con-
vert into scrapie-like conformers in transgenic flies (16).
However, the molecular mechanism underlying the resis-
tance of rabbits to prion diseases is not well understood.
The misfolding of proteins associated with neurodegener-
ative diseases such as prion diseases has been traditionally
and widely studied in dilute solutions (3,17–21). However,
these amyloidogenic proteins form fibrils in a physiological
crowded environment (22–29). Macromolecular crowding
takes place not only inside the cell (23–25), but also in the
extracellular matrix of tissues (23) and at membrane sur-
faces (30). It has been demonstrated that macromolecular
crowding significantly accelerates the misfolding of several
amyloidogenic proteins, such as human a-synuclein
(31,32), the amyloid b peptide (30), human apolipoprotein
C-II (33), human Tau protein (28), and human PrP (28).
PrPC is a highly conserved GPI-anchored cell surface glyco-
protein and the conformational conversion of PrPC into its
pathogenic isoform PrPSc is believed to occur on the cell
surface or in the crowded extracellular matrix (34,35).
Thus, clarifying how macromolecular crowding on the cell
surface or in the extracellular matrix influences the confor-
mational transition and amyloid formation of PrP in vivo is
of importance to elucidate the mechanism for the resistance
of rabbits to prion diseases.
To understand the molecular mechanism underlying the
resistance of rabbits to prion diseases, we have investigated
and compared the effects of macromolecular crowding on
amyloid formation of the recombinant rabbit/human/bovine
full-length PrPs by using several biophysical methods, such
as ThT binding, TEM, atomic force microscopy, FTIRdoi: 10.1016/j.bpj.2011.08.018
1484 Zhou et al.spectroscopy, far-ultraviolet CD, and MS. Our results indi-
cated that a crowded, cell-like environment strongly in-
hibited rabbit PrP misfolding but remarkably accelerated
human/bovine PrP misfolding, by fitting the data to a
sigmoidal equation (20,28,36). Furthermore, amyloid fibrils
formed by the rabbit PrP had remarkably different structure
and a PK-resistant feature from those formed by the proteins
from human and cow.EXPERIMENTAL PROCEDURES
Details regarding the experimental procedures are in the Supporting
Material.Materials
The crowding agents, Ficoll 70 and dextran 70, were purchased from Sigma-
Aldrich (St. Louis, MO). ThT was also obtained from Sigma-Aldrich.
Guanidine hydrochloride was obtained from Promega (Madison, WI).
ProteinaseK,TritonX-100, and ureawere purchased fromAmeresco (Solon,
OH). All other chemicals used were made in China and were of analytical
grade.Expression and purification of prion proteins
Recombinant full-length rabbit/human/bovine PrPs were expressed in
Escherichia coli, isolated on a Ni-NTA agarose column, and further purified
by high-performance liquid chromatography on a C4 reversed-phase column
(Shimadzu, Kyoto, Japan) as described by Bocharova and co-workers (17).
Purified rabbit/human/bovine PrPs were confirmed by SDS-polyacrylamide
gel electrophoresis (PAGE) and MS to be single species with an intact
disulfide bond. The concentrations of the rabbit PrP, human PrP, and bovine
PrP were determined by their absorbance at 280 nm using the molar extinc-
tion coefficient values of 57,995, 57,995, and 63,495 M1 cm1, respec-
tively, deduced from the composition of the proteins online.Seeding experiments
Mature fibrils formed by the rabbit/human/bovine PrP were sonicated on ice
using a probe sonicator for 30 s (interval of 5 s, 200W) to produce the seeds
used in the seeding experiments. The kinetics of fibril formation of samples
with 0.5% (v/v) preformed seed fibrils at the initial time were monitored by
ThT binding assays.Sarkosyl-soluble SDS-PAGE
Rabbit/human PrP amyloid formation was carried out as stated above,
during the incubation time, 20 ml samples were taken out and added with
2.5 ml of 100 mM Tris-HCl (pH 7.0) and 2.5 ml of 20% Sarkosyl. The
mixture was left at room temperature for 30 min, and then mixed with
2X loading buffer (without b-mercaptoethanol and no heating) and sepa-
rated by 15% SDS-PAGE. Gels were stained by Coomassie Blue.RESULTS
Effects of macromolecular crowding
on kinetics of amyloid formation
of the rabbit/human/bovine PrP
The enhanced fluorescence emission of the dye ThT has
been frequently used for monitoring the kinetics of amyloidBiophysical Journal 101(6) 1483–1492fibril formation, which is a specific marker for the b-sheet
conformation of fibril structures (20,28,37). In this study,
the effects of two nominally inert polymeric additives,
Ficoll 70 and dextran 70, on kinetics of amyloid formation
of the recombinant rabbit/human/bovine full-length PrP
were examined by ThT binding assays (Fig. 1), as a function
of crowder concentration. Ficoll 70 and dextran 70 are
widely accepted as reasonable models for the principal
crowding components in living cells (25).
For rabbit PrP, time dependence of ThT fluorescence
as a function of crowder concentration is shown in Fig. 1,
A and B. As shown in Fig. 1, A and B, the rabbit PrP allowed
efficient amyloid formation in the absence of a crowding
agent, however, amyloid formation of the rabbit PrP was
strongly inhibited by Ficoll 70 and dextran 70 at 150–
200 g/l on the investigated timescale, accompanied by a
remarkable decline of the maximum ThT intensity.
For comparison, two amyloidogenic proteins, human PrP
and bovine PrP, were explored (Fig. 1, C–F). As shown in
Fig. 1, C and E, the presence of Ficoll 70 at concentrations
of 150 and 200 g/l in the reaction systems both significantly
accelerated amyloid formation of the human PrP and bovine
PrP on the investigated timescale. Similarly, the presence of
dextran 70 at 150–200 g/l in the reaction systems also signif-
icantly accelerated fibril formation of the human PrP and
bovine PrP on the investigated timescale (Fig. 1, D and F).
To elucidate the mechanisms of the inhibitory effect of
macromolecular crowding on amyloid formation of the
rabbit PrP and the enhancing effect of macromolecular
crowding on fibril formation of the human PrP and bovine
PrP, a sigmoidal equation (20,28,36) was used to fit the
kinetic data, yielding three kinetic parameters A, the lag
time, and k, which are summarized in Table 1. As shown
in Table 1 and Fig. 1, in contrast to the proteins from human
and cow, fibril formation of the rabbit protein was not accel-
erated by crowding agents. However, the onset fibril forma-
tion in the absence of a crowding agent was very similar.
The onset of fibril formation of the rabbit protein appeared
even slightly earlier than that of the other two proteins
(Fig. 1). The addition of a crowding agent such as dextran
70 at 200 g/l remarkably decreased the rate constant for
the growth of the rabbit PrP fibrils and significantly de-
creased the amount of the rabbit PrP fibrils represented by
A (Table 1). On the contrary, the addition of 200 g/l dextran
70 dramatically accelerated both steps of human PrP fibril-
lization (Table 1), resulting in a lag time of 0.99 h in the
presence of dextran 70, which is 4.9-fold decreased com-
pared with that in the absence of a crowding agent (4.82 h),
and a rate constant for the growth of fibrils of 6.49 h1,
which is 6.4-fold larger than that in the absence of a crowd-
ing agent (1.01 h1). The addition of 200 g/l dextran 70 also
markedly accelerated both steps of bovine PrP fibrillization,
albeit to a lower extent than the human PrP (Table 1). These
results indicate that the crowding agents Ficoll 70 and
dextran 70 have different effects on fibrillization of the
FIGURE 1 Effects of macromolecular crowding
on amyloid formation of rabbit/human/bovine
PrPs. Rabbit (A and B), human (C and D), and
bovine (E and F) PrPs in the absence and presence
of Ficoll 70 (A, C, and E) or dextran 70 (B, D, and
F), monitored by ThT fluorescence. All experi-
ments were repeated at least once. The final
concentrations of all PrPs were 10 mM. The crowd-
ing agent concentrations were 0 (open square),
150 g/l (solid circle), and 200 g/l (solid triangle),
respectively. The data were fitted to a sigmoidal
equation, and the solid lines represent the best fit.
The corresponding kinetic parameters from A–F
are summarized in Table 1.
Fibrillization of the Rabbit PrP 1485recombinant PrPs from different species: although these
agents dramatically promote fibril formation of the proteins
from human and cow, they appear to significantly inhibit
fibrillization of the rabbit protein. Therefore, under crowded
physiological conditions, amyloid fibril formation of the
rabbit PrP was markedly slower than those of the human/
bovine proteins and the amount of the rabbit PrP aggregates
was significantly less than that of the human/bovine PrP
aggregates (Fig. 1 and Table 1).
For a thorough analysis and control of the effects of crowd-
ing agents, complementary approaches were used such as
testing the effects of additives in seeding experiments
(Fig. 2) or measurements of the decrease of monomeric
protein (Figs. S1 and S2 in the Supporting Material). As
shown in Fig. 2, in the absence of a crowding agent, the addi-
tion of seeds significantly reduced the lag time of fibrilliza-
tion of the recombinant PrPs from rabbit, human, and cow.
The addition of 200 g/l Ficoll 70 not only decelerated both
steps of seed-induced rabbit PrP fibrillization, resulting in
a lag time of 1.62 h in the presence of Ficoll 70, which is1.6-fold increased compared with that in the absence of
a crowding agent (1.02 h), and a rate constant for the growth
of fibrils of 2.51 h1, which is 1.7-fold decreased compared
with that in the absence of a crowding agent (4.24 h1), but
also significantly decreased the amount of rabbit PrP fibrils
(Fig. 2). By contrast, the addition of 200 g/l Ficoll 70 remark-
ably accelerated both steps of seed-induced human/bovine
PrP fibrillization (Fig. 2). To semiquantify the decrease of
monomeric protein in the presence of crowding agents, we
carried out Sarkosyl-soluble SDS-PAGE experiments. As
shown in Fig. S1, a clear band corresponding to Sarkosyl-
soluble human PrPmonomers was observedwhen the human
protein was incubated in the absence of a crowding agent
for 8 h, whereas the human PrP monomer band was observed
when the human protein was incubated with 200 g/l Ficoll
70 for a much shorter time (1–2 h). As shown in Fig. S2,
a clear band corresponding to Sarkosyl-soluble rabbit PrP
monomers was observed when the rabbit protein was incu-
bated with 150 g/l Ficoll 70 for 8 h, whereas the rabbit PrP
monomer band was observed when the rabbit protein wasBiophysical Journal 101(6) 1483–1492
TABLE 1 Kinetic parameters of amyloid formation of rabbit/
human/bovine PrPs in the absence and presence of Ficoll 70 or
dextran 70 as determined by ThT binding assays at 37C
PrP Crowding agent A Lag time (h) k (h1)
Rabbit PrP 0 3535 6 4.575 0.14 1.675 0.18
150 g/l Ficoll 70 1235 2 5.355 0.14 1.145 0.09
200 g/l Ficoll 70 73.55 1.7 3.855 0.20 1.665 0.26
150 g/l dextran 70 79.15 2.7 5.905 0.76 1.645 0.63
200 g/l dextran 70 65.05 2.1 5.475 0.19 0.805 0.08
Human PrP 0 84.65 1.9 4.825 0.17 1.015 0.09
150 g/l Ficoll 70 81.15 1.4 1.405 0.11 1.895 0.19
200 g/l Ficoll 70 91.05 1.2 1.325 0.11 3.405 0.56
150 g/l dextran 70 1265 2 1.545 0.05 2.505 0.16
200 g/l dextran 70 1455 1 0.995 0.03 6.495 0.40
Bovine PrP 0 73.95 2.0 9.655 0.34 0.735 0.09
150 g/l Ficoll 70 72.25 1.2 3.085 0.12 1.035 0.07
200 g/l Ficoll 70 80.45 0.7 3.025 0.05 2.785 0.17
150 g/l dextran 70 90.35 1.6 4.135 0.15 1.915 0.25
200 g/l dextran 70 1185 1 4.115 0.04 1.845 0.07
Best-fit values of these kinetic parameters were derived from nonlinear least
squares modeling of a sigmoidal equation as described in the Materials and
Methods (in the Supporting Material) to the data plotted in Fig. 1. Errors
shown are5SE.
1486 Zhou et al.incubated in the absence of a crowding agent for a shorter
time (4–6 h). The above results indicate that although the
crowding agents dramatically promote fibril formation of
the proteins from human and cow, they significantly inhibit
fibrillization of the rabbit protein by stabilizing its native
state.FIGURE 2 Effects of macromolecular crowding on seed-induced
amyloid formation of rabbit/human/bovine PrPs. Rabbit (A), human (B),
and bovine (C) PrPs in the absence (open circle) and presence of 200 g/l
Ficoll 70 (solid triangle) with 0.5 (v/v) seeds, monitored by ThT fluores-
cence. All experiments were repeated at least once. The final concentrations
of all PrPs were 10 mM. The data were fitted to a sigmoidal equation, and
the solid lines represent the best fit.Effects of macromolecular crowding on
morphology of the rabbit/human/bovine
PrP samples
TEM was employed to study the morphology of rabbit/
human/bovine PrP samples incubated under different condi-
tions. Fig. 3, A–C, shows TEM images of rabbit PrP samples
incubated in dilute solutions or in the presence of Ficoll 70
at concentrations of 150 and 200 g/l. The amount of fibrils
formed by the rabbit PrP in the presence of 150–200 g/l
Ficoll 70 (Fig. 3, B and C), appears to be markedly less
than that in the absence of a crowding agent (Fig. 3 A) on
the same timescale. The results from TEM are in accordance
with those from ThT binding assays, further supporting the
conclusion that macromolecular crowding significantly
inhibits fibril formation of rabbit PrP. Atomic force micros-
copy was used to probe the structural order in the rabbit PrP
aggregates (Fig. S3). In the absence of a crowding agent, the
fibrils formed by the rabbit PrP appear as a long and straight
structure after incubation for 8 h (Fig. S3 A). In the presence
of 150 g/l Ficoll 70, however, sporadic short fibrils and gran-
ular aggregates were observed when rabbit PrP samples
were incubated for 8 h (Fig. S3 B). Fig. 3, D–F, shows
TEM images of bovine PrP samples incubated in diluted
buffer or in the presence of 150–200 g/l Ficoll 70. In the
absence of a crowding agent, the fibrils formed by theBiophysical Journal 101(6) 1483–1492bovine PrP appear as a long, twisted, and branched structure
after incubation for 16 h (Fig. 3 D), which is similar to those
produced from the human PrP (28), but different from those
produced from the rabbit PrP (Fig. 3 A) in the absence of
FIGURE 3 Transmission electron micrographs
of rabbit/bovine PrP samples at physiological pH
after incubation under different conditions. Rabbit
(A–C) and bovine (D–F) PrP samples were incu-
bated for 8 h (A–C), 16 h (D), or 10 h (E and F)
in the absence of a crowding agent (A and D) and
in the presence of 150 g/l Ficoll 70 (B and E) or
200 g/l Ficoll 70 (C and F), respectively. A 2%
(w/v) uranyl acetate solution was used to nega-
tively stain the fibrils. The scale bars represent
200 nm.
Fibrillization of the Rabbit PrP 1487a crowding agent. In the presence of 150 or 200 g/l Ficoll 70,
however, abundant short fibrillar fragments and spherical or
ellipsoidal particles were observed when bovine PrP
samples were incubated for 10 h (Fig. 3, E and F), which
is similar to those produced from the human PrP in the pres-
ence of 150 g/l Ficoll 70 (28). The above results indicated
that macromolecular crowding also caused the bovine PrP
to form short fibrils and nonfibrillar particles. Furthermore,
the morphology of bovine PrP fibrils formed in crowded
solutions is similar to that of PrPSc purified from scrapie-
infected hamster brain (38) or bovine spongiform encepha-
lopathy-affected cow brain (39). Together, we showed that a
crowded physiological environment could play an important
role in the pathogenesis of prion diseases by accelerating
human/bovine PrP misfolding and inducing human/bovine
PrP fibril fragmentation.TABLE 2 Secondary structure composition of amyloid fibrils
formed by rabbit/human/bovine PrPs as determined from










a-Helix ~1655 18.7 12.5 15.1
b-Sheet ~1614–1630 37.5 43.9 41.0
Turn ~1663–1689 17.1 23.4 25.5
Random coil ~1645 26.7 20.2 18.4Comparison of the secondary structures
of the rabbit/human/bovine PrP fibrils
Prion propagation involves the conversion of PrPC into
PrPSc, shifting from a predominantly a-helical to b-sheet
structure (40–42). Herein, FTIR was used to compare the
secondary structures of rabbit/human/bovine PrP fibrils.
The shape and position of amide I’ (1600–1700 cm1) of
FTIR bands provide detailed information on the secondary
structure of proteins (40,42), and amide I’ peaks in the range
of 1611–1630 cm1 are characteristic for b-sheet formed by
amyloid fibrils (43). The infrared spectra of rabbit/human/
bovine PrP fibrils in the absence of a crowding agent were
fitted using a combination of Gaussian peaks with maxima
taken from second derivatives of FTIR spectra (Fig. S4,
A–C), and the secondary structure contents were estimated
by area of different peaks, which are summarized in Table 2.
As shown in Table 2, the percentage of b-sheet in rabbit PrPfibrils was 37.5%, whereas those in human PrP fibrils and
bovine PrP fibrils were 43.9% and 41.0%, respectively.
The percentage of a-helix in rabbit PrP fibrils was 18.7%,
whereas those in human PrP fibrils and bovine PrP fibrils
were 12.5% and 15.1%, respectively. Clearly, amyloid
fibrils formed by the rabbit protein contained more a-helix
structure and less b-sheet structure than the human/bovine
proteins.
CD spectroscopy was used to confirm the significant dif-
ferences in secondary structures between rabbit PrP fibrils
and human/bovine PrP fibrils. Fig. 4 shows the CD spectra
of native rabbit/human/bovine PrP and rabbit/human/bovine
PrP fibrils formed in the absence of a crowding agent. As
shown in Fig. 4, A–C, in the absence of a crowding agent
and before incubation, the CD spectra measured for
rabbit/human/bovine PrP sample had double minima at
208 and 222 nm, indicative of predominant a-helical struc-
ture. After incubation for 12 and 16 h, respectively, a single
minimum around 218 nm was observed for human PrP and
bovine PrP samples (Fig. 4, B and C), which is typical of
predominant b-sheet structure and a characteristic for amy-
loid formation. After incubation for 12 h, however, a single
minimum around 210 nm (but not 218 nm) was observed forBiophysical Journal 101(6) 1483–1492
FIGURE 4 Secondary structural changes of rabbit (A), human (B), and
bovine (C) PrP isoforms monitored by far-ultraviolet CD. Curve a: native
rabbit/human/bovine PrPs in the absence of a crowding agent. Curve b:
amyloid fibrils produced from rabbit, human, and bovine PrPs incubated
for 12, 12, 16 h, respectively, in the absence of a crowding agent.
FIGURE 5 Concentration-dependent proteinase K-digestion assays of
rabbit (A), human (B), and bovine (C) PrP fibrils. Samples were treated

1488 Zhou et al.rabbit PrP fibril samples (Fig. 4 A), further supporting the
conclusion reached by FTIR spectroscopy that rabbit PrP
fibrils contained more a-helix structure and less b-sheet
structure than human/bovine PrP fibrils. In other words,
amyloid fibrils formed by the rabbit PrP had a remarkably
different structure feature from those formed by the proteins
from human and cow.with PK for 1 h at 37 C at PK/PrP molar ratios as follows: 1:1000
(lane 2), 1:500 (lane 3), 1:100 (lane 4), and 1:50 (lane 5). PK concentration:
0.4 mg/ml (lane 2), 0.8 mg/ml (lane 3), 4 mg/ml (lane 4), and 8 mg/ml
(lane 5). The controls with zero protease in the absence of a crowding agent
were loaded in lane 1. Protein molecular mass markers were loaded on
lane M: restriction endonuclease Bsp98 I (25.0 kDa), b-lactoglobulin
(18.4 kDa), and lysozyme (14.4 kDa). Amyloid fibrils were produced
from rabbit, human, and bovine PrPs incubated for 12, 12, and 16 h, respec-
tively, in the absence of a crowding agent. Protein fragments were separated
by SDS-PAGE and detected by silver staining.Comparison of proteinase K-digestion products
of the rabbit/human/bovine PrP fibrils
PK resistance activity has been widely used to distinguish
PrPC from PrPSc since the pioneering studies of Prusiner
and co-workers (44,45). Limited exposure of PrPSc to PK
digestion generates a fragment of 19–21-kDa encompassingBiophysical Journal 101(6) 1483–1492residues ~90–231, named PrP-27–30 (17,38,44–46). As
shown in Fig. 5,B andC, and Fig. S5,B andC, amyloid fibrils
produced from the human/bovine prion proteins generated
PK-resistant fragments of 15–16-kDa after PK digestion
for 1 h, which share the primary N-terminal sequence with
PrP-27–30 type 2 but lacks the GPI anchor (46,47). As PK
concentration or digestion time increased, the bands corre-
sponding to such fragments became fainter. Human/bovine
PrP fibrils also generated three short fragments (12-, 10-,
and 8-kDa bands), which are similar to those of mouse PrP
reported previously (18). By contrast, amyloid fibrils
produced from the rabbit PrP did not generate a PK-resistant
fragment of 15–16-kDa at all PK concentrations (or digestion
time) examined, but generated two short fragments (11- and
9-kDa bands) (see Fig. 5 A and Fig. S5 A).
Matrix-assisted laser desorption/ionization time-of-flight
MS was used to examine PK-digestion products of rabbit/
human/bovine PrP fibrils in the absence of a crowding
Fibrillization of the Rabbit PrP 1489agent. As shown in Fig. 6 A, amyloid fibrils formed by the
rabbit PrP did not generate a PK-resistant fragment of
15–16-kDa, but generated several short fragments (11.43-,
10.98-, 10.58-, 9.02-, and 5.93-kDa bands). On the contrary,
amyloid fibrils formed by the human and bovine proteins
did generate such PK-resistant fragments of 15.42- and
15.71-kDa, respectively (Fig. 6, B and C).
Nano-liquid chromatography LTQ Orbitrap MS (Ther-
moFisher, Waltham, MA) was used to identify PK-digestion
products of rabbit/human/bovine PrP fibrils in the absence
of a crowding agent. By carefully analyzing the total ion
chromatogram of PK-digestion products of rabbit PrP fibrils
(Fig. S6 A), we once again showed that amyloid fibrils
produced from the rabbit PrP did not generate a PK-resistant
fragment of 15–16-kDa, but generated several short frag-
ments, such as fragments encompassing residues 134–228
(Fragment 1, measured mass 11488.29 Da, theoretical
mass 11489.68 Da) and 138–228 (Fragment 2, measured
mass 11034.46 Da, theoretical mass 11036.14) (Fig. S6 B
and Table S1). By contrast, three PK-resistant fragments
encompassing residues 97–231 (Fragment 1, measured
mass 15554.06 Da, theoretical mass 15554.40 Da), residues
99–231 (Fragment 2, measured mass 15337.85 Da, theoret-
ical mass 15339.19 Da), and residues 92–231 (Fragment 3,
measured mass 15961.41 Da, theoretical mass 15963.80 Da)
for human PrP fibrils were identified by comparison of mea-
sured and theoretical masses (Fig. S7, A and B, and
Table S1). Two PK-resistant fragments encompassing resi-
dues 108–241 (Fragment 1, measured mass 15355.91 Da,
theoretical mass 15356.19 Da) and 102–240 (Fragment 2,
measured mass 15821.91 Da, theoretical mass 15822.64 Da)
for bovine PrP fibrils were identified (Table S1). In sum-
mary, amyloid fibrils formed by the rabbit PrP had remark-
ably different PK-resistant features from those formed by
the proteins from human and cow.FIGURE 6 Matrix-assisted laser desorption/ionization time-of-flight
mass spectra of proteinase K-digestion products of rabbit (A), human (B),
and bovine (C) PrP fibrils. Amyloid fibrils, produced from rabbit, human,
and bovine PrPs incubated for 12, 12, and 16 h, respectively, in the absence
of a crowding agent, were treated with 4 mg/ml PK for 40 min at 37C.
Amyloid fibrils formed by rabbit PrP did not generate a PK-resistant
core fragment of 15–16-kDa (A), but those formed by human and bovine
PrPs generated such PK-resistant core fragments of 15.42-kDa (B) and
15.71-kDa (C), respectively.DISCUSSION
The inability of a protein to adopt its native and soluble con-
formation (protein misfolding) in its crowded physiological
environment is the origin of an increasing number of human
diseases such as CJD (22). The direct consequence of
macromolecular crowding is that little space is left for addi-
tional macromolecules, which reduce their configurational
entropy and therefore increase their free energy (24). As a
consequence, protein misfolding is theoretically favored
by macromolecular crowding (24). Experimentally, macro-
molecular crowding has been shown to accelerate amyloid
formation of a wide range of proteins, such as human a-syn-
uclein (31,32), human Tau protein (28), and human PrP (28).
Two recent studies have suggested that macromolecular
crowding can significantly accelerate protein aggregation
and may play a significant role in aggregation-related
diseases (48,49). This study demonstrated that macromolec-
ular crowding significantly inhibited fibrillization of theBiophysical Journal 101(6) 1483–1492
1490 Zhou et al.rabbit PrP by stabilizing its native state, but dramatically
accelerated fibril formation by the human/bovine PrP,
indicating yet another biologically relevant system that
is strongly influenced and distinguished by the crowding
of inert macromolecules. Our additional experiments indi-
cated that the two crowding agents had a similar impact
on the structure of rabbit PrP monomers and aggregates
(Fig. S8). Clearly, it is the crowding effect but not the direct
PrP-crowder interactions that blocked fibril formation of the
rabbit PrP.
For the resistance to prion diseases, somewidely accepted
generalizations are as follows.1), Laboratory animals such
as mice, hamsters, and rats, are susceptible to a variety of
prions, including those from sheep, humans, and cattle (8).
2), Rabbits are among the few animal species that exhibit
resistance to prion diseases from different species (8,9).
3), Critical amino acid residues inhibiting PrPSc formation
are located throughout the rabbit PrP sequence and the resis-
tance of rabbits to prion diseases is due to multiple rabbit
PrP-specific amino acid residues (9,10). The overall se-
quence homology between the rabbit PrP and the human/
bovine PrP is 88.6%/87.5%, respectively, and only 22/28
amino acids are different in the mature PrP molecules
between rabbit and human/cattle (9,10). Our data showed
that in contrast to the proteins from human and cow, fibril
formation of the rabbit protein was not accelerated by
crowding agents. However, the onset fibril formation in
the absence of a crowding agent was very similar. Therefore,
the strong inhibition of fibril formation of the rabbit protein
from the crowded physiological environment could be one
of the reasons why rabbits are resistant to prion diseases.
We then designed a novel (to our knowledge) triple mutant
G99N/L137I/S173N of the rabbit PrP, in which three rabbit-
specific amino acid residues (99G, 137L, and 173S) (10)
were replaced by the corresponding amino acids of the
human PrP. As shown in Fig. S9, the fibrillization kinetics
of G99N/L137I/S173N differed greatly from that of wild-
type rabbit PrP (Fig. 1 A) and macromolecular crowding
did not inhibit but dramatically promoted fibril formation
of such a mutant of the rabbit PrP. The above results demon-
strated that the sequence did affect both the kinetics and the
inhibitory effect of crowding agents on fibrillization of the
rabbit PrP.
Besides the opposite influences of macromolecular
crowding on fibril formation of the rabbit PrP and the
human/bovine PrP, rabbit PrP aggregates and human/bovine
PrP aggregates also show some differences in their sec-
ondary structures. As judged from FTIR, the percentages
of b-sheet in human PrP fibrils and bovine PrP fibrils were
43.9% and 41.0%, respectively, which are similar to those
of PrPSc purified from scrapie-infected hamster brain
(43%) (42) and fibrils formed by recombinant full-length
hamster PrP (40–44%) (50). However, the percentage of
b-sheet in rabbit PrP fibrils was 37.5%. Clearly, amyloid
fibrils formed by the rabbit PrP contained less b-sheet struc-Biophysical Journal 101(6) 1483–1492ture than the human/bovine/hamster PrPs. It should be
mentioned that an in-register parallel b-sheet structure
formed by the C-terminal end may be a general feature of
PrP fibrils prepared in vitro (51–53). Most recently, Fernan-
dez-Funez and co-workers (16) have found that the 15B3
conformational antibody does not recognize rabbit PrP
aggregates in elder flies but hamster and mouse PrP accumu-
late 15B3-positive (PrPSc-like) conformers in elder flies.
Taken together, these results suggest that compared with
other mammalian PrP aggregates, rabbit PrP aggregates
possess unique structural characteristics.
In this study, we demonstrate that under crowded physio-
logical conditions, the amount of rabbit PrP aggregates is
significantly less than that of human/bovine PrP aggregates.
These results are consistent with recent data concerning
rabbit/hamster/mouse PrP misfolding in vivo (16). The re-
cent data have shown that the amounts of PrP aggregates
in the elder flies expressing hamster PrP and mouse PrP
are large and moderate, respectively, whereas the elder flies
expressing rabbit PrP reveal only traces of PrP aggregates
(16). Rabbit PrP does not induce spongiform degeneration
and does not convert into scrapie-like conformers in trans-
genic flies (16), supporting the hypothesis that the rabbit
PrP cannot be converted into the pathogenic PrPSc-like con-
formers spontaneously (10). It is known that if the process of
PrPSc multiplication is slower than the degradation, PrPSc
will be cleared throughout an animal’s lifetime (54,55). In
a crowded physiological environment, only traces of rabbit
PrP aggregates are observed (16), likely due to the strong
inhibition of rabbit PrP misfolding by the crowded environ-
ment (this work). Such a crowded environment, however,
remarkably accelerates human/bovine PrP misfolding. Fur-
thermore, we find that human/bovine PrP aggregates gen-
erate PK-resistant fragments of 15–16-kDa but rabbit PrP
aggregates do not generate such a fragment at all PK con-
centrations or digestion time examined. We show that
crowding alters reaction rates in different protein forms
and that there are some structural differences in the fibrils.
They are both contributors to the different kinetics of fibril-
lization. Together, our results suggest that the strong inhibi-
tion of fibrillization of the rabbit PrP by the crowded
physiological environment and the difference in structure
and PK-resistant feature between amyloid fibrils formed
by the rabbit PrP and those formed by the proteins from
human and cow could be two of the reasons why rabbits
are resistant to prion diseases, and the different kinetics of
fibrillization is the important effect to the biological
phenomenon. It should be pointed out that PrPSc is a compli-
cated assembly that contains the PrP core and other cofac-
tors (6,56). These cofactors, which we shall study in detail
in the future, could play an important role in the pathogenic
function of human/bovine PrPSc and in the resistance of
rabbits to prion diseases. Future issues also include: what
is the reason for the poor infectivity of amyloid fibrils
derived from recombinant PrPC (56)?
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